BNGO
Bionano Genomics, Inc.Company with tickers: BNGO
CIK
1411690
CUSIP
09075F404
Shares Outstanding
11,475,000
13F Activity (30d)
26 filings
24 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $6,687,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $3,139,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-7,897,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-8,303,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.76 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.76 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |